This study aimed to explore the relationship between adenosine monophosphate-activated protein kinase (AMPK), especially mitochondrial AMPK (mAMPK), and the formation of fatty liver in goose. In this study, 12 healthy 70-day-old male Landes goose were randomly divided into a control group (normal liver group) fed ad libitum and a overfed group (fatty liver group) for in vivo experiments. The main isoforms of AMPKα, its subcellular distribution, and the protein content of AMPKα1 in whole-cell and mitochondrial lysates of normal and fatty livers were detected by Western blotting and immunofluorescence techniques. Goose primary hepatocytes were treated with high concentrations of glucose or palmitic acid, and the protein content of AMPKα1 in the control group, 100 mmol·L-1 glucose group, and 0.5 mmol·L-1 palmitic acid group was detected by Western blotting. The mitochondrial AMPK competitive inhibitor peptide (mitoAIP) was overexpressed in AML12 cells, and the content of AMPK downstream proteins in the empty vector control group and the mitoAIP overexpression group were detected by Western blotting. mitoAIP was overexpressed in AML12 cells and treated with 2 mmol·L-1 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR). The content of AMPK downstream proteins in the empty vector control group, the AICAR+empty vector control group, and the AICAR+mitoAIP overexpression group was detected by Western blotting. mitoAIP was overexpressed in AML12 cells, and the mitochondrial membrane potential was measured in the empty vector control group and the mitoAIP overexpression group using flow cytometry. mitoAIP and MitoTimer were overexpressed in AML12 cells, and the oxidative stress level of mitochondria in the pMitoTimer+empty vector control group and the pMitoTimer+mitoAIP overexpression group was measured using flow cytometry. mitoAIP was overexpressed in AML12 cells treated by oleic acid, and the fat deposition in the oleic acid+empty vector control group and the oleic acid+mitoAIP overexpression group was analyzed using Oil Red O staining. All cell experiments were repeated at least 3 times. The study found that AMPKα1 was the predominant isoform in goose hepatocytes, primarily localized in the mitochondrial fraction and specifically on the outer mitochondrial membrane. Both total AMPKα1 (tAMPKα1) and phosphorylated AMPKα1 (pAMPKα1) protein levels in whole-cell and mitochondrial lysates were lower in fatty liver compared to normal liver (P < 0.05, P < 0.01), the reduction in mitochondrial tAMPKα1 did not reach statistical significance. High glucose treatment did not significantly affect tAMPKα1 and pAMPKα1 protein abundance, while palmitic acid treatment reduced pAMPKα1 protein abundance in the mitochondrial fraction (P=0.079). In AML12 cells, overexpression of mitoAIP significantly increased the protein abundance of pAMPKα1, tAMPKα1, pACC1, and tACC1 in mitochondria (P < 0.05, P < 0.01), but had no significant effect on the protein abundance of AMPK and ACC1 in whole-cell lysate. AICAR treatment significantly increased the abundance of pAMPKα1 and pACC1 proteins in whole cell lysates (P < 0.05), but significantly reduced the abundance of pAMPKα1, tAMPKα1, pACC1, tACC1, and tULK1 proteins in the mitochondrial fraction (P < 0.05). Overexpression of mitoAIP significantly inhibited the AICAR-induced reduction in pACC1 abundance in whole cells (P < 0.05), but did not significantly affect the abundance changes of other proteins induced by AICAR treatment. mitoAIP overexpression caused a decrease in mitochondrial membrane potential, an increase in mitochondrial oxidative stress levels, and an increase in cellular fat content (P < 0.05, P < 0.01). In summary, mitoAIP differs from the known global AIP in regulating the abundance of AMPK and its substrate proteins in whole cells and mitochondria, as well as mitochondrial membrane potential and oxidative stress levels, suggesting that mAMPK plays a unique role in regulating mitochondrial function. The results of mitoAIP overexpression in AML12 cells suggest that the reducion of the phosphorylated mAMPK content in goose fatty liver may induce increase of fat deposition, decrease of mitochondrial membrane potential, and increase of oxidative stress level. However, these effects may also be regulated by other mechanisms.